Stuart A Arbuckle is EVP, COO of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 49,691 shares of VRTX, which is worth approximately $25 Million. The most recent transaction as insider was on Feb 01, 2023, when has been sold 38,221 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.7K
0% 3M change
12.14% 12M change
Total Value Held $25 Million

Stuart A Arbuckle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2023
BUY
Grant, award, or other acquisition
-
38,221 Added 28.42%
96,252 Common Stock
Dec 06 2022
BUY
Grant, award, or other acquisition
-
12,753 Added 18.02%
58,031 Common Stock
Aug 15 2022
SELL
Open market or private sale
$6,719,527 $303.05 p/Share
22,173 Reduced 32.87%
45,278 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
$1,022,251 $155.57 p/Share
6,571 Added 8.88%
67,451 Common Stock
Aug 10 2022
SELL
Open market or private sale
$54,211 $301.17 p/Share
180 Reduced 0.29%
60,880 Common Stock
Aug 10 2022
BUY
Exercise of conversion of derivative security
$9,956 $155.57 p/Share
64 Added 0.1%
61,060 Common Stock
Aug 09 2022
SELL
Open market or private sale
$1,712,576 $300.98 p/Share
5,690 Reduced 8.53%
60,996 Common Stock
Aug 09 2022
BUY
Exercise of conversion of derivative security
$299,628 $155.57 p/Share
1,926 Added 2.81%
66,686 Common Stock
May 16 2022
SELL
Open market or private sale
$33,299 $250.37 p/Share
133 Reduced 0.2%
64,760 Common Stock
May 02 2022
SELL
Open market or private sale
$80,778 $263.98 p/Share
306 Reduced 0.47%
64,760 Common Stock
Feb 24 2022
SELL
Payment of exercise price or tax liability
$1,651,074 $227.86 p/Share
7,246 Reduced 10.02%
65,066 Common Stock
Feb 17 2022
SELL
Payment of exercise price or tax liability
$959,336 $232.51 p/Share
4,126 Reduced 5.4%
72,312 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$722,730 $237.74 p/Share
3,040 Reduced 3.82%
76,438 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
38,375 Added 32.56%
79,478 Common Stock
Nov 15 2021
SELL
Open market or private sale
$562 $187.4 p/Share
3 Reduced 0.01%
41,103 Common Stock
May 17 2021
SELL
Open market or private sale
$23,575 $216.28 p/Share
109 Reduced 0.26%
41,103 Common Stock
Feb 25 2021
SELL
Open market or private sale
$777,676 $214.0 p/Share
3,634 Reduced 8.12%
41,103 Common Stock
Feb 24 2021
SELL
Payment of exercise price or tax liability
$630,518 $217.57 p/Share
2,898 Reduced 6.08%
44,737 Common Stock
Feb 18 2021
SELL
Open market or private sale
$1,658,039 $211.89 p/Share
7,825 Reduced 14.11%
47,635 Common Stock
Feb 17 2021
SELL
Payment of exercise price or tax liability
$1,321,320 $211.75 p/Share
6,240 Reduced 10.11%
55,460 Common Stock
Feb 11 2021
SELL
Open market or private sale
$1,089,102 $211.23 p/Share
5,156 Reduced 7.71%
61,700 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$664,110 $214.16 p/Share
3,101 Reduced 4.43%
66,856 Common Stock
Feb 03 2021
SELL
Open market or private sale
$332,944 $214.25 p/Share
1,554 Reduced 2.17%
69,957 Common Stock
Feb 03 2021
BUY
Exercise of conversion of derivative security
$134,452 $86.52 p/Share
1,554 Added 2.13%
71,511 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
34,778 Added 33.21%
69,957 Common Stock

Also insider at

RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
IMGN
ImmunoGen, Inc. Healthcare
SAA

Stuart A Arbuckle

EVP, COO
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX